Early Access — free while we kick the tires
EdgarHawk

JHS JOHN HANCOCK INCOME SECURITIES TRUST Insider Trading

Latest: Director Bought $12K of Shares · May 2026

Multiple insiders have been active at JOHN HANCOCK INCOME SECURITIES TRUST (JHS): 5 distinct insiders account for 6 buy filings and 0 sell filings as of May 2026. Its highest-significance filing in the last 90 days: Director Hurtsellers Christine bought $12K, transaction dated May 2026.

6 filings analyzed · Latest 2026-05-07

Get alerts for JHS

Free Form 4 email alerts, scored for significance — see how.

Buys
6
Sells
0
Insiders
5
Direction
Net buying

JOHN HANCOCK INCOME SECURITIES TRUST leadership

General Counsel
Christopher Sechler — Secretary and Chief Legal Officer
Chair
Hassell H. McClellan — Chairperson of the Board

Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after the trade — the edge is concentrated in that first month (n ≈ 5,579, 2024-2026). Past results don't predict the future. How we measure this ↗

May 2026
2026-05-07
high
1,071 shares
$12,000
@ $11.20
Significance 5

Director Christine Hurtsellers purchases over 1,000 shares of JHS at current trading levels.

Director Christine Hurtsellers bought approximately 1,071 shares of John Hancock Income Securities Trust in a single transaction at prevailing market prices. The stock is currently trading modestly below its recent highs, having declined from its peak but risen slightly over the past month. As a board member rather than an operational executive, Hurtsellers' purchase reflects directorial confidence in the fund's value, though her trade lacks the insider knowledge advantage that an officer with day-to-day operational insight would possess. The purchase amount is meaningful but modest relative to the fund's overall capitalization, suggesting a measured conviction rather than an aggressive bet. Without visibility into whether Hurtsellers has a track record of prior purchases or sales in this stock, or additional context about other board members' recent activity, this trade represents a single director's decision to add to her holdings at current valuations.

January 2026
2026-01-27
low
130 shares
$1,528
@ $11.75
Significance 3

Director Kenneth J Phelan bought 130 shares of JHS at $11.75 (Jan 26), initiating position; current price $11.76

Kenneth J Phelan, a director of John Hancock Income Securities Trust, initiated a position by purchasing 130 shares at $11.75 on January 26, 2026, for a total value of $1,527.50. The transaction size is modest relative to typical institutional holdings and amounts to a low-dollar entry into the security. At the current price of $11.76, the position is nearly at the purchase level, with the stock trading within its 52-week range and having posted mixed recent momentum (+1.8% over 30 days, +1.2% over 90 days). While the director's cross-ticker track record shows a 90-day win rate of 100.00% across 11 prior buys, this represents Phelan's first recorded transaction at JHS, so no same-ticker historical pattern is available to assess whether this purchase follows a demonstrated strategy at this particular security.

2026-01-27
medium
725 shares
$8,540
@ $11.78
Significance 5

Director Phelan Kenneth J bought 725 JHS shares at $11.78 (Jan 27), expanding position by 557.7% to 855 shares total.

Kenneth J Phelan, a director of John Hancock Income Securities Trust, executed a substantial open-market purchase of 725 shares at $11.78 on 2026-01-27, increasing his holdings from 130 to 855 shares—a 557.7% expansion. This follows a similar buy of 30 shares the prior day at the same ticker, suggesting sequential accumulation. The current price of $11.76 sits -1.3% from the 52-week high ($11.91) and 1.8% above 30-day levels, placing the transaction near recent peaks. Across his cross-ticker buy history, Phelan achieved a 100.00% win rate over 90 days with an average 90d return of +10.8%; however, his same-ticker history at JHS is too early to measure (prior buy was 2026-01-26). The transaction magnitude and consecutive-day activity pattern are noteworthy, but the absence of measurable same-ticker outcomes limits inference about this specific investment thesis.

April 2025
2025-04-11
low
1,030 shares
$11,227
@ $10.90
Significance 4

Director Wright Thomas Rowe purchases 1,030 shares of JHS at $10.90; stock now trading -4.2% over 30 days.

Director Wright Thomas Rowe initiated a position in John Hancock Income Securities Trust with a purchase of 1,030 shares at $10.90, adding a $11,227.00 commitment. The current price of $10.81 reflects a -4.2% decline over the past 30 days, suggesting market weakness since the transaction. This buy represents a first position for the insider (0 shares pre-transaction), and his cross-ticker track record shows 8 prior open-market buys, indicating a pattern of opportunistic purchasing behavior. The stock's position near the 52-week low of $10.72 and its -8.4% discount from the 52-week high place this transaction in a context of relative depressed valuations, though the modest transaction size and recent price momentum warrant standard observation.

January 2025
2025-01-15
low
911 shares
$10,067
@ $11.05
Significance 3

Bacic William K purchases 911 shares of JHS at $11.05 on 2025-01-14; initial position for insider with 8 prior open-market buys across other tickers.

Bacic William K acquired 911 shares of John Hancock Income Securities Trust at $11.05, establishing a new position in the fund. This represents his first transaction in JHS; he held 0 shares prior. While the insider has executed 8 prior open-market purchases across other tickers, this opening position in JHS is not yet supported by a pattern of additional activity or accumulation at this specific ticker. The current price of $11.14 reflects modest appreciation from the $11.05 purchase price, positioning the stock 5.6% below its 52-week high and down 4.5% over the past 90 days. As a single initial buy with no accompanying same-ticker purchase history, the transaction documents a new entry without additional context regarding the insider's investment thesis or conviction level at this security.

December 2024
2024-12-26
medium
980 shares
$11,301
@ $11.53
Significance 6

Ellison Noni L bought 980 shares of JHS at blended average $11.53 in 2 transactions, raising holdings 88.8% to 2,083 shares

Ellison Noni L executed 2 separate purchases totaling 980 shares for $11,301.40 at a blended average price of $11.53, nearly doubling her post-transaction holdings to 2,083 shares from 1,103 shares. The purchase price of $11.53 is slightly above the current price of $11.26 and near the 52-week high of $11.80, occurring when the stock has declined 4.6% from its 52-week peak and 2.1% over 30 days. Her prior transaction at this same ticker (October 2023) generated a 90-day return of +8.4%, though her cross-ticker buy history shows a 100% win rate at 90 days with an average return of +15.9%, establishing a pattern of favorable post-purchase outcomes. The substantial increase in position size (88.8% net change) combined with the timing near recent highs and the track record of positive subsequent returns merit attention to whether this accumulation reflects forward expectations for JHS.

Insiders here also file at